Res 2010-044 - Laserfiche WebLink

Home Browse Search

Research Subaward Agreement Institution /Organization ( "Prime Recipient ") Institution /Organization ( "Subrecipient ") Name: Texas State University -San Marcos Name: City of San Marcos, Texas Prime Award No.: W912Li -07 -2 -3061 Subaward No.: 8000001194.2 CFDA #: Agency: Amount Funded This Action: Est. Total (if incrementally funded) $40,574.00 r Awarding The Adjutant General of Texas Subaward Period of Performance: Estimated Project Period (if incrementally funded): Budget Period: From: To: From: To: r September 30, 2009 September 30, 2010 Project Title: ARNG Advance Law Enforcement Rapid Response Training (ALERRT) Reporting Requirements (Check here if applicable: FX_ See Attachment 4) r ARRA Funds (Attachment 4A) Terms & Conditions 1) Prime Recipient hereby awards a cost reimbursable subaward, as described above, to Subrecipient. The statement of work and budget for this subaward are (check one): f As specified in Subrecipient's proposal dated F or (X as shown in Attachment 5. In its performance of the subaward work, Subrecipient shall be an independent entity and not an employee or agent of Prime Recipient. 2) Prime Recipient Shall reimburse Subrecipient not more often than monthly for allowable costs. All invoices shall be submitted using Subrecipient's standard invoice, but at a minimum shall include current and cumulative costs (including cost sharing), subaward number, and certification as to truth and accuracy of invoice. Invoices that do not reference Prime Recipient's Subaward Number sh be returned t o Subrecipient. Invoices and questions con- cerning invoice receipt or payments should be directed to the appropriate party's Administrative Contact as shown in Attachments 3A & 3B. 3 A fi statement of cumulative costs incurred, including cost sharing, marked "FINAL" must be submitted to Prime Recipient's Administrative Contact, as shown in Attachments 3A and 3B, NOT LATER THAN sixty (60) days after subaward end date. The final statement of costs shall constitute Subrecipient's final financial report. 4) All payments shall be considered provisional and subject to adjustment within the total estimated cost in the event such adjustment is necessary as a result of an adverse audit finding against the Subrecipient. 5) Matters concerning the technical performance of this subaward should be directed to the appropriate party's Principal Investigator, as shown in Attachments 3A and 3B. Technical reports are required as shown above, "Reporting Requirements ". 6) Matters concerning the request or negotiation of any changes in the terms, conditions, or amounts cited in this subaward agreement, and any changes requiring prior approval, should be directed to the appropriate party's F dmi n Istrative Contact, as shown in Attachments 3A & 3B. Any such changes made to this subaward agreement require the written approval of each party's Authorized Official as shown in Attachments 3A & 3B. 7) Each party shall be responsible for its negligent acts or omissions and the negligent acts or omissions of its employees, officers, or director's, to the extent allowed by law. 8) Either party may terminate this subaward with thirty days written notice to the appropriate party's Administrative Contact as shown in Attachments 3A & 3B. Prime Recipient shall pay Subrecipient for termination costs as allowable under OMB Circular A -21 or A -122 or 45 CFR Part 74 Appendix E, "Principles for Determining Costs Applicable to Research and Development under Grants and Contracts with Hospitals" as applicable. 9) No -cost extensions re quire the approval of the Prime Recipient. Any requests for a no -cost extension should be addressed to and received by the (Administrative Contact, as shown in Attachments 3A & 3B, not less than thirty (30) days prior to the desired effective date of the requested change. 10) The Subaward is subject to the terms and conditions of the Prime Award and other special terms and conditions, as identified in Attachment 2. 11) By signing below Subrecipient makes the certifications and assurances shown in Attachments 1 and 2. Subrecipient also assures that it will comply with applicable statutory and regulatory requirements specified in the Research Terms & Conditions Appendix C found at w_n _, o http: / /ww fa /dins /policy /rtcJappc.pdf. By an Autho ' ed Official of Prime cipient L By arAluo d Official of Subrecipient ate ate